Georgia has joined a 48-state legal settlement requiring C.R. Bard Inc. and its parent company to pay $60 million for the deceptive marketing of transvaginal surgical mesh devices. Thousands of women implanted with surgical mesh have made claims that they suffered serious complications resulting from the devices, including erosion of mesh through organs, pain during intercourse, and voiding dysfunction.

Read the full article:
Capitol Beat News Service